兆科眼科-B涨近10% 近期与印尼药企PT Ferron就分销老花眼药达成协议

Core Viewpoint - Zhaoke Ophthalmology-B (06622) experienced a nearly 10% increase in stock price, reaching HKD 3.7 with a trading volume of HKD 6.55 million following the announcement of a distribution and supply agreement in Indonesia for its innovative drug BRIMOCHOL PF, aimed at treating presbyopia [1] Company Summary - Zhaoke Ophthalmology has signed a distribution and supply agreement with PT Ferron Par Pharmaceuticals, a leading pharmaceutical company in Indonesia [1] - The agreement grants PT Ferron exclusive rights to import, promote, distribute, market, and sell BRIMOCHOL PF in Indonesia [1] - Zhaoke Ophthalmology will receive an upfront payment and may earn additional milestone payments based on certain achievements [1]